Shamburg News · 8-K filed Oct 2, 2026, 5:27 PM EDT

ChronoScale Completes Sale of Ekso Bionics Unit and Announces AI Infrastructure Agreements

CHRN · ChronoScale Holdings Corp

  • Leadership change
  • Other event
  • Material agreement
  • Reg FD disclosure
  • Acquisition
  • Other
  • Materiality: high

On September 30, 2026, ChronoScale Holdings Corporation completed the sale of its wholly owned subsidiary Ekso Bionics, Inc. The company terminated Ekso Chief Operating Officer Jason C. Jones effective September 30, 2026, and Ekso entered into a Severance and Release Agreement providing a lump-sum cash payment of $243,750 and COBRA premium coverage for up to nine months. On October 1, 2026, the company announced a contract extension with an existing AI infrastructure customer and a new customer agreement, which it said provide for annualized run-rate revenue of $1 billion by calendar Q3 2027.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 5.02, 5.03, 7.01, 9.01, accession 0001493152-26-045612.

Written from the filing by Shamburg Markets. Figures are as reported by the company.